IN184589B
(no)
*
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
WO2001037804A2
(en)
*
|
1999-11-22 |
2001-05-31 |
Universal Preservation Technologies, Inc. |
Preservation and formulation of bioactive materials
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
JP5118798B2
(ja)
*
|
2000-03-07 |
2013-01-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アデノウイルス製剤
|
US7153472B1
(en)
|
2000-11-22 |
2006-12-26 |
Quadrant Drug Delivery Limited |
Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
|
US6827250B2
(en)
*
|
2001-06-28 |
2004-12-07 |
Microchips, Inc. |
Methods for hermetically sealing microchip reservoir devices
|
WO2003048665A1
(en)
|
2001-12-03 |
2003-06-12 |
Massachusetts Institute Of Technology |
Microscale lyophilization and drying methods for the stabilization of molecules
|
CA2476859C
(en)
*
|
2002-03-13 |
2011-09-20 |
Collagenex Pharmaceuticals, Inc. |
Water-based delivery systems
|
KR100725973B1
(ko)
*
|
2002-08-16 |
2007-06-11 |
마이크로칩스 인코포레이티드 |
전열적 제거를 이용한 제어 방출 장치 및 방법
|
WO2004022033A1
(en)
*
|
2002-09-04 |
2004-03-18 |
Microchips, Inc. |
Method and device for the controlled delivery of parathyroid hormone
|
MXPA05003222A
(es)
*
|
2002-09-27 |
2005-07-26 |
Powderject Res Ltd |
Particulas revestidas con acido nucleico.
|
WO2004033034A1
(en)
|
2002-10-04 |
2004-04-22 |
Microchips, Inc. |
Medical device for neural stimulation and controlled drug delivery
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
CA2510196C
(en)
|
2002-12-20 |
2014-04-01 |
Generipharm, Inc. |
Intracutaneous injection
|
AU2004229465B2
(en)
*
|
2003-04-09 |
2010-04-29 |
The United States Of America Department Of Veterans Affairs |
Compositions and methods related to production of erythropoietin
|
ATE494885T1
(de)
*
|
2003-04-25 |
2011-01-15 |
Boston Scient Scimed Inc |
Feste arzneimittelformulierung und vorrichtung zu ihrer aufbewahrung und kontrollierten abgabe
|
US7892205B2
(en)
|
2003-06-06 |
2011-02-22 |
Boston Scientific Scimed, Inc. |
Device and method for delivering micronized therapeutic agents in the body
|
DE602004029396D1
(de)
*
|
2003-11-03 |
2010-11-11 |
Microchips Inc |
Medizinprodukt zum messen von glucose
|
EP1765455A2
(en)
*
|
2004-06-01 |
2007-03-28 |
Microchips, Inc. |
Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant
|
US7537590B2
(en)
*
|
2004-07-30 |
2009-05-26 |
Microchips, Inc. |
Multi-reservoir device for transdermal drug delivery and sensing
|
US7772182B2
(en)
*
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
US20060029551A1
(en)
*
|
2004-08-05 |
2006-02-09 |
Kui Liu |
Stable particle formulations of erythropoietin receptor agonists
|
ATE424928T1
(de)
*
|
2004-09-01 |
2009-03-15 |
Microchips Inc |
Behältervorrichtungen mit mehreren verschlüssen zur gesteuerten abgabe oder exponierung des behälterinhalts
|
EP2995330B1
(en)
*
|
2004-09-10 |
2021-12-08 |
Becton, Dickinson and Company |
Patch-like infusion device
|
AU2006208131A1
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
CN101511170B
(zh)
*
|
2005-12-22 |
2014-03-26 |
奥克伍德药业有限公司 |
可升华持续释放传递系统和其制造方法
|
ES2351527T3
(es)
|
2006-05-30 |
2011-02-07 |
Intarcia Therapeutics, Inc |
Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
MX2009010405A
(es)
*
|
2007-03-30 |
2010-02-03 |
Helix Biopharma Corp |
Composicion en vesicula de lipido bifasico y metodo para tratar la displasia cervical mediante suministro intravaginal.
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US8968786B2
(en)
|
2007-06-22 |
2015-03-03 |
Board Of Regents, The University Of Texas System |
Formation of stable submicron peptide or protein particles by thin film freezing
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
KR20110103961A
(ko)
|
2008-11-16 |
2011-09-21 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
저점도 고농축 현탁액
|
WO2010059253A2
(en)
*
|
2008-11-24 |
2010-05-27 |
Massachusets Institute Of Technology |
Methods and compositions for localized agent delivery
|
KR102093612B1
(ko)
|
2009-09-28 |
2020-03-26 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
EP2544721B1
(en)
*
|
2010-03-09 |
2017-12-06 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations
|
US9072668B2
(en)
|
2010-03-09 |
2015-07-07 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
IN2012DN06581A
(no)
|
2010-03-17 |
2015-10-23 |
Novaliq Gmbh |
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN103442695B
(zh)
|
2011-03-10 |
2016-05-04 |
Xeris药物公司 |
肠胃外注射用肽药物的稳定制剂
|
CN103561724B
(zh)
|
2011-05-25 |
2016-06-29 |
诺瓦利克有限责任公司 |
给药给甲的药物组合物
|
KR101790388B1
(ko)
|
2011-05-25 |
2017-10-25 |
노바리크 게엠베하 |
부분불소화된 알칸에 기초된 국소 제약학적 조성물
|
PL2773331T3
(pl)
|
2011-10-31 |
2016-08-31 |
Xeris Pharmaceuticals Inc |
Preparaty do leczenia cukrzycy
|
CN104066442B
(zh)
|
2012-01-23 |
2018-05-18 |
诺瓦利克有限责任公司 |
基于半氟化烷烃的稳定蛋白质组合物
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
BR112015005008B1
(pt)
|
2012-09-12 |
2022-04-19 |
Novaliq Gmbh |
Composições de alcano semifluorado
|
BR112015004997B1
(pt)
|
2012-09-12 |
2022-09-13 |
Novaliq Gmbh |
Composições oftálmicas contendo misturas de alcanos semifluorados
|
JP6542128B2
(ja)
|
2013-01-11 |
2019-07-10 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニルのプロドラッグ
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
CA2899089C
(en)
*
|
2013-03-15 |
2021-10-26 |
Biogen Ma Inc. |
Factor ix polypeptide formulations
|
MX370207B
(es)
|
2013-07-23 |
2019-12-05 |
Novaliq Gmbh |
Composiciones estabilizadas de anticuerpos.
|
US8986732B2
(en)
|
2013-08-12 |
2015-03-24 |
Helix Biopharma Corporation |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
US10159646B2
(en)
|
2013-08-12 |
2018-12-25 |
Altum-Avro Pharma Partnership |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
EP4272763A3
(en)
|
2013-09-11 |
2024-02-14 |
Eagle Biologics, Inc. |
Liquid protein formulations containing organophosphates
|
EP3049114B1
(en)
|
2013-09-27 |
2021-11-10 |
Massachusetts Institute of Technology |
Carrier-free biologically-active protein nanostructures
|
CA2943034C
(en)
|
2014-03-24 |
2022-06-14 |
Biogen Ma Inc. |
Lyophilized factor ix formulations
|
WO2016010538A1
(en)
|
2014-07-16 |
2016-01-21 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
AU2015300944B2
(en)
|
2014-08-06 |
2019-07-11 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
SG11201702614SA
(en)
|
2014-10-01 |
2017-04-27 |
Eagle Biolog Inc |
Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
CN116212048A
(zh)
|
2015-08-12 |
2023-06-06 |
麻省理工学院 |
纳米颗粒的细胞表面偶联
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
CN113662928A
(zh)
|
2015-09-30 |
2021-11-19 |
诺瓦利克有限责任公司 |
用于眼部给药的半氟化化合物
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
TWI814219B
(zh)
|
2016-05-16 |
2023-09-01 |
美商因塔希亞治療公司 |
升糖素受體選擇性多肽和彼之使用方法
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
US11472856B2
(en)
|
2016-06-13 |
2022-10-18 |
Torque Therapeutics, Inc. |
Methods and compositions for promoting immune cell function
|
PL3442480T3
(pl)
|
2016-06-23 |
2020-04-30 |
Novaliq Gmbh |
Sposób podawania miejscowego
|
MX2019003363A
(es)
|
2016-09-22 |
2019-10-02 |
Novaliq Gmbh |
Composiciones farmaceuticas para usarse en la terapia de la blefaritis.
|
JP6869336B2
(ja)
|
2016-09-23 |
2021-05-12 |
ノバリック ゲーエムベーハー |
シクロスポリンを含む眼科用組成物
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
AU2018253944B2
(en)
|
2017-04-21 |
2022-09-15 |
Dermaliq Therapeutics, Inc. |
Iodine compositions
|
CN110650734A
(zh)
|
2017-05-12 |
2020-01-03 |
诺瓦利克有限责任公司 |
治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物
|
US10646569B2
(en)
|
2017-05-16 |
2020-05-12 |
Bhami's Research Laboratory, Pvt. Ltd. |
High concentration protein formulations with reduced viscosity
|
BR112019024987A2
(pt)
|
2017-06-02 |
2020-06-16 |
Xeris Pharmaceuticals, Inc. |
Formulações de fármaco de molécula pequena resistente à precipitação
|
CA3074826A1
(en)
|
2017-09-05 |
2019-03-14 |
Torque Therapeutics, Inc. |
Therapeutic protein compositions and methods of making and using the same
|
WO2019063551A1
(en)
|
2017-09-27 |
2019-04-04 |
Novaliq Gmbh |
OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES
|
CA3076567A1
(en)
|
2017-10-04 |
2019-04-11 |
Novaliq Gmbh |
Ophthalmic compositions
|
EP3758676A1
(en)
|
2018-03-02 |
2021-01-06 |
Novaliq GmbH |
Pharmaceutical compositions comprising nebivolol
|
WO2019217637A1
(en)
*
|
2018-05-09 |
2019-11-14 |
Biomatrica, Inc. |
Stabilization of proteins in biological samples
|
JP7500550B2
(ja)
|
2018-10-12 |
2024-06-17 |
ノバリック ゲーエムベーハー |
乾性眼疾患の治療のための眼科用組成物
|
CN113661006A
(zh)
|
2019-02-05 |
2021-11-16 |
林迪生物科学公司 |
分离的细胞培养物组分以及用于从液体细胞培养基中分离其的方法
|
EP4069324A4
(en)
|
2019-12-06 |
2024-01-10 |
Guangzhou Bioseal Biotech Co., Ltd. |
FLUID FIBRINOGEN THROMBIN PASTE
|
WO2023044455A2
(en)
*
|
2021-09-16 |
2023-03-23 |
Team Medical Llc |
Rna stabilization
|